The Updated NHS Commercial Framework for New Medicines

March 3, 2025

Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)

February 14, 2025

MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?

February 12, 2025

The Covington European Life Sciences Symposium 2025

February 4, 2025

The Covington European Life Sciences Symposium 2025

February 4, 2025

MHRA Consults on New UK Pre-Market Medical Device Measures

December 2, 2024

MHRA Consults on New UK Pre-Market Medical Device Measures

November 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024